| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michał Tomaszewski, Karolina M Stępień, Joanna Tomaszewska, Stanisław J Czuczwa. Statin-induced myopathies. Pharmacological reports : PR. vol 63. issue 4. 2012-02-10. PMID:22001973. |
clinical trials commonly define statin toxicity as myalgia or muscle weakness with creatine kinase (ck) levels greater than 10 times the normal upper limit. |
2012-02-10 |
2023-08-12 |
Not clear |
| D Pell. [Statin myopathy--rarity or reality?]. Vnitrni lekarstvi. vol 56. issue 9 Suppl. 2011-01-27. PMID:21137170. |
the clinical symptoms of statin myopathy include myalgia or muscle weakness, tiredness, cramps and/or creatinkinase activity increases (ck). |
2011-01-27 |
2023-08-12 |
Not clear |
| Christopher W K Lam, Michael H M Chan, Chun K Won. Severe acute respiratory syndrome: clinical and laboratory manifestations. The Clinical biochemist. Reviews. vol 25. issue 2. 2010-06-17. PMID:18458712. |
clinical and general laboratory manifestations included fever, chills, rigor, myalgia, malaise, diarrhoea, cough, dyspnoea, pneumonia, lymphopenia, neutrophilia, thrombocytopenia, and elevated serum lactate dehydrogenase (ld), alanine aminotransferase (alt) and creatine kinase (ck) activities. |
2010-06-17 |
2023-08-12 |
Not clear |
| Anil John, Anjum S John, Kaabi Saad Al, Rajvir Singh, Moutaz Derbala, Rafie Yakou. Myalgia during interferon therapy--does it warrant monitoring muscle enzymes? Tropical gastroenterology : official journal of the Digestive Diseases Foundation. vol 30. issue 3. 2010-04-21. PMID:20306756. |
we prospectively monitored the creatine kinase (ck) and lactate dehydrogenase (ld) levels in all our patients who reported myalgia during treatment and noted that muscle enzymes remained within normal range throughout the duration of treatment. |
2010-04-21 |
2023-08-12 |
Not clear |
| Joyce M Cooper, Alison L Jone. Neuroleptic malignant syndrome or a statin drug reaction? A case report. Clinical neuropharmacology. vol 32. issue 6. 2010-02-25. PMID:19952877. |
eight years later, she represents with symptoms suggesting recurrence of nms including elevated ck level and myalgia, however, without limb rigidity. |
2010-02-25 |
2023-08-12 |
Not clear |
| Paul M Coen, Michael G Flynn, Melissa M Markofski, Brandt D Pence, Robert E Hanneman. Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage. Metabolism: clinical and experimental. vol 58. issue 7. 2009-07-13. PMID:19411087. |
the efficacy of exercise and statin treatment combined, and its impact on myalgia and serum creatine kinase (ck) have not been completely addressed. |
2009-07-13 |
2023-08-12 |
human |
| Paul M Coen, Michael G Flynn, Melissa M Markofski, Brandt D Pence, Robert E Hanneman. Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage. Metabolism: clinical and experimental. vol 58. issue 7. 2009-07-13. PMID:19411087. |
there was no abnormal sustained increase in ck or reports of myalgia after the addition of exercise training to rosuvastatin treatment. |
2009-07-13 |
2023-08-12 |
human |
| Amy K Kearns, Cherie L Bilbie, Priscilla M Clarkson, C Michael White, Kim A Sewright, Kevin S O'Fallon, Mamatha Gadarla, Paul D Thompso. The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. Atherosclerosis. vol 200. issue 1. 2008-11-04. PMID:18261731. |
the creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. hydroxy-methyl-glutaryl co-enzyme a (hmg-coa) reductase inhibitors or statins are well tolerated by most patients, but can produce a variety of skeletal muscle problems including myalgia, creatine kinase (ck) elevations and clinically important rhabdomyolysis. |
2008-11-04 |
2023-08-12 |
human |
| Yi-Mei Wang, Yue Zhang, Zhi-Bin Y. Rhabdomyolysis following recent severe coxsackie virus infection in patient with chronic renal failure: one case report and a review of the literature. Renal failure. vol 28. issue 1. 2006-08-30. PMID:16526325. |
this study reports a 39-year-old female patient with chronic renal failure who presented with fever, myalgia, anuria, edema, vomiting, diarrhea, exacerbation of renal function, elevation of serum ck, ck-mb, ck-mm, myoglobin, and liver function abnormality. |
2006-08-30 |
2023-08-12 |
Not clear |
| J P Klein, U Fiedler, H Appel, A Quante, M C Jockers-Scherüb. Massive creatine kinase elevations with quetiapine: report of two cases. Pharmacopsychiatry. vol 39. issue 1. 2006-03-29. PMID:16453254. |
we thus suggest ck assessment when myalgia occurs with neuroleptic treatment. |
2006-03-29 |
2023-08-12 |
Not clear |
| Chantale Simard, Paul Poirie. Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. The Canadian journal of cardiology. vol 22. issue 2. 2006-03-28. PMID:16485049. |
the recurrence of muscle pain after washout and the ck increase both supported the hypothesis that ezetimibe alone can be linked to myalgia. |
2006-03-28 |
2023-08-12 |
Not clear |
| Russell A Wilke, Jason H Moore, James K Burmeste. Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage. Pharmacogenetics and genomics. vol 15. issue 6. 2005-12-15. PMID:15900215. |
study subjects were recruited from the general patient population served by marshfield clinic, a large horizontally integrated multispecialty group practice located in central wisconsin, and case assignment was based upon both subjective (myalgia) and objective inclusion criteria [elevated serum creatine kinase (ck) levels]. |
2005-12-15 |
2023-08-12 |
human |
| Russell A Wilke, Jason H Moore, James K Burmeste. Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage. Pharmacogenetics and genomics. vol 15. issue 6. 2005-12-15. PMID:15900215. |
an association was identified between the non-functional cyp3a5*3 allele and the magnitude of serum ck elevation in case patients experiencing myalgia. |
2005-12-15 |
2023-08-12 |
human |
| Chung-Wen Chen, Ming-Hong Chan. Rhabdomyolysis induced by fenoverine: a case report and literature review. Acta neurologica Taiwanica. vol 14. issue 3. 2005-11-10. PMID:16252617. |
acute onset of myalgia, proximal muscle weakness and high creatinine phosphokinase (ck) occurred. |
2005-11-10 |
2023-08-12 |
Not clear |
| H Köller, O Neuhaus, M Schroeter, H-P Hartun. [Myopathies under therapy with lipid-lowering agents]. Der Nervenarzt. vol 76. issue 2. 2005-09-27. PMID:15609055. |
myopathies ranging from myalgia to clinically asymptomatic creatine kinase (ck) elevation and to life-threatening rhabdomyolysis belong to the most important complications of lipid-lowering therapies with fibrates and 3-hydroxy-3-methylglutaryl coenzyme a (hmg-coa) reductase inhibitors, i.e., statins. |
2005-09-27 |
2023-08-12 |
Not clear |
| T L Lee, T C A. Prevention of succinylcholine-induced myalgia with lidocaine pretreatment. Journal of anesthesia. vol 5. issue 3. 2005-02-07. PMID:15278625. |
pretreatment with lidocaine, 3 mg.kg(-1) iv, significantly reduced the incidence of myalgia from 40.4% of control group to 12.8% lidocaine-treated group, but not the ck levels. |
2005-02-07 |
2023-08-12 |
Not clear |
| M Krasnianski, S Neudecker, M Deschauer, S Zier. [The clinical spectrum of limb-girdle muscular dystrophies type 2I in cases of a mutation in the "fukutin-related- protein"-gene]. Der Nervenarzt. vol 75. issue 8. 2004-12-01. PMID:15221067. |
another patient had myalgia, cramps, elevated serum ck and dilatative cardiomyopathy without muscle weakness and wasting. |
2004-12-01 |
2023-08-12 |
Not clear |
| Matthew C Kiernan, Peter Bullpitt, Jane H L Cha. Mitochondrial dysfunction and rod-like lesions associated with administration of beta2 adrenoceptor agonist formoterol. Neuromuscular disorders : NMD. vol 14. issue 6. 2004-07-20. PMID:15145339. |
a patient is presented who developed myalgia and muscle weakness, associated with an elevation of creatine kinase (ck) during treatment with formoterol. |
2004-07-20 |
2023-08-12 |
Not clear |
| Kayser Caglar, Mükerrem Safali, Izzet Yavuz, Zeki Odabaşi, Müjdat Yenicesu, Abdülgaffar Vura. Colchicine-induced myopathy with normal creatine phosphokinase level in a renal transplant patient. Nephron. vol 92. issue 4. 2003-07-17. PMID:12399640. |
we suggest that colchicine myopathy should be taken into account in patients who have been on colchicine therapy and had unexplained myalgia as well as elevated aminotransferase levels even with normal ck levels. |
2003-07-17 |
2023-08-12 |
Not clear |
| N Sato, S Okamoto, T Mori, R Watanabe, Y Hamano, J Kawamura, D Ishihara, Y Iked. Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia. Hematology (Amsterdam, Netherlands). vol 7. issue 2. 2003-06-23. PMID:12186701. |
however, 51 months after the first episode of myositis, she again noted severe myalgia and was diagnosed with a recurrence of polymyositis based on high serum creatinine kinase (ck) and the findings of magnetic resonance imaging (mri). |
2003-06-23 |
2023-08-12 |
Not clear |